Boostrix

GSK Boostrix

Pharma

FDA ups nod for GSK's Boostrix to protect babies from pertussis

The FDA expanded use of Boostrix (Dtap) to mothers in their third trimester of pregnancy to safeguard against pertussis (whooping cough) in infants.

Kevin Dunleavy Oct 10, 2022 10:08am

GlaxoSmithKline lab

GSK expanding Hungary vaccine plant, adding 100 jobs

Mar 13, 2017 12:26pm